AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25845406
Drug: Non-hormonal vaginal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-hormonal vaginal gel (GEL)
Trial: 23273638
Drug: Tualang honey
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tualang honey (3 mls intraoperatively, followed by 4 mls orally three times daily for seven days) + Sultamicillin (25mg/kg IV three times daily for two days, then orally twice daily for five days)
Trial: 23273638
Drug: Sultamicillin (25mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sultamicillin (25mg/kg IV for two days, then orally twice daily for five days)
Trial: 20084368
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg MDMA
Trial: 20084368
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg MDMA
Trial: 16171020
Drug: Topical application
RxNorm normalized name: Talc Topical application Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical application of 25% metronidazole-containing mucoadhesive lipogel
Trial: 12849803
Drug: Embryo selection
RxNorm normalized name: human embryo tissue preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Embryo selection based on sequential evaluation of both pronuclear morphology and embryo morphology on day 3
Trial: 10383498
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg, clarithromycin 500 mg, and amoxycillin 1000 mg (OAC)
Trial: 10383498
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg, clarithromycin 250 mg, and metronidazole 400 mg (OMC)
Trial: 30590857
Drug: Reboxetine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (4 mg) plus hyoscine butylbromide (20 mg)
Trial: 28002986
Drug: Copper supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Copper supplementation (1000 mg per day)
Trial: 20942287
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at acupoints compound general anesthesia (group B)
Trial: 20942287
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at non‐acupoints compound general anesthesia (group C)
Trial: 18380632
Drug: Warfarin arm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin arm of SPORTIF III
Trial: 10917401
Drug: Fluvoxamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (100 to 200 mg/day) combined with neuroleptics
Trial: 8702053
Drug: Urodilatin (URO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urodilatin (URO) infusion (20 ng/kg bw/min)
Trial: 8702053
Drug: Urodilatin (URO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urodilatin (URO) infusion
Trial: 1687130
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg Salbutamol (after last dose)
Trial: 26782254
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with primary tumor resection (PTR)
Trial: 25007865
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate 100 μg once daily
Trial: 25007865
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate 200 μg once daily
Trial: 25007865
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate 100 μg and 200 μg once daily
Trial: 21055090
Drug: Standardized dust
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized dust mite allergen specific immunotherapy (SIT)
Trial: 10559514
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of LNMMA (8 and 16 micromol/min) followed by intracoronary administration of 250 mcg nitroglycerin
Trial: 10559514
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of LNMMA
Trial: 8565164
Drug: OPC-18790 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPC-18790 (5 micrograms.kg‐1.min‐1, low dose)
Trial: 8565164
Drug: OPC-18790 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPC-18790 (10 micrograms.kg‐1.min‐1, high dose)
Trial: 6129869
Drug: Terfenadine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 20 mg 3 times a day
Trial: 6129869
Drug: Chlorpheniramine maleate
RxNorm normalized name: Chlorpheniramine Maleate
DrugBank: Chlorpheniramine (DB01114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorpheniramine maleate 4 mg 3 times a day
Trial: 6129869
Drug: Terfenadine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine (up to 200 mg 3 times a day)
Trial: 31864496
Drug: Stripping twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stripping twice before testicular tissue collection
Trial: 17443125
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg nicotine via nasal spray
Trial: 18815772
Drug: Matched placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matched placebo via nasal spray
Trial: 16035374
Drug: Probiotic multivitamin
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic multivitamin and mineral supplement (verum)
Trial: 9661595
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (mid and high doses)
Trial: 9661595
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated estrogen (late pubertal dose)
Trial: 2655812
Drug: Levamisole (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (50 mg, 2 to 5 tablets twice a week for 1 year)
Trial: 30895578
Drug: Early diabetes
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early diabetes testing (HBA1c, 50 g glucose challenge test, or 100 g oral glucose tolerance test) before 24 weeks
Trial: 28344197
Drug: OM3-CA administered
RxNorm normalized name: Ca 2+
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OM3-CA administered after a meal
Trial: 28344197
Drug: OM3-CA administered
RxNorm normalized name: Ca 2+
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OM3-CA administered in fasting conditions
Trial: 28344197
Drug: OM3-CA administered
RxNorm normalized name: Ca 2+
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OM3-CA administered before a meal
Trial: 26447705
Drug: Steroid injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid injections with local anesthetic mixed with deposteroid and 3 rounds of sham PRF
Trial: 19808130
Drug: ARF15 BID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARF15 BID (15 microg/2 mL twice daily)
Trial: 19808130
Drug: ARF30 QD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARF30 QD (30 microg/4 mL once daily)
Trial: 16394955
Drug: Phosphatidylserine (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylserine (750 mg daily for 10 days)
Trial: 15700504
Drug: Concurrent smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent smoking intervention (during alcohol treatment)
Trial: 15700504
Drug: Concurrent smoking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent smoking intervention
Trial: 2953527
Drug: Leukotriene D4
RxNorm normalized name: Leukotriene D4
DrugBank: Leukotriene D4 (DB11858)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukotriene D4 (LTD4) inhalation
Trial: 23595153
Drug: Full-dose twice-daily
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full-dose twice-daily nevirapine
Trial: 23595153
Drug: Nevirapine dose-escalation
RxNorm normalized name: Nevirapine
DrugBank: Nevirapine (DB00238)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nevirapine dose-escalation
Trial: 17184645
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (100 mg)
Trial: 16926261
Drug: GnRH agonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH agonist triptorelin 0.1 mg administered on day 6 after ICSI
Trial: 2427843
Drug: Celiprolol 200
RxNorm normalized name: celiprolol 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celiprolol 200 mg once daily
Trial: 8405139
Drug: Mode I:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mode I: 20 mg hydrocortisone (HC) at 0700 h and 10 mg HC at 1900 h
Trial: 8405139
Drug: Mode II:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mode II: 30 mg HC at 0700 h and placebo at 1900 h
Trial: 8405139
Drug: Mode III:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mode III: Placebo at 0700 h and 30 mg HC at 1900 h
Trial: 24812492
Drug: Old 'sticky'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Old 'sticky' tablet
Trial: 24812492
Drug: New tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New tablet formulations (larger API crystal size, 30% more excipients)
Trial: 24812492
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg and 50 mg liquid‐filled hard gelatin capsule
Trial: 24812492
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg reference tablet
Trial: 11851638
Drug: S 18326
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S 18326 (0.5 mg h‐1)
Trial: 11851638
Drug: S 18326
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S 18326 (3 mg h‐1)
Trial: 10703776
Drug: Intravenous tPA
RxNorm normalized name: tPA
DrugBank: Phorbol 12-myristate 13-acetate diester (DB17045)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous tPA (recombinant alteplase)
Trial: 1350562
Drug: Terlipressin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (2 mg initially and 1 mg every 4 hr for 24 hr)
Trial: 1350562
Drug: Somatostatin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin (250 micrograms as a bolus and continuous infusion of 250 micrograms/hr for 24 hr)
Trial: 2578707
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg acyclovir four times a day for 12 weeks
Trial: 23134891
Drug: Phosphatidylcholine (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylcholine (750 mg)
Trial: 18823461
Drug: 660 mg
RxNorm normalized name: lactulose 660 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 660 mg of aspirin
Trial: 16084069
Drug: Low-dose estrogen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose estrogen replacement therapy (ultralow dose micronized estradiol)
Trial: 12190127
Drug: Endoscopy-assisted treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopy-assisted treatment with angulated drills and screwdrivers
Trial: 30328294
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (14,000 U weekly for 8 months)
Trial: 29121975
Drug: 1 cup
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 cup of espresso coffee plus 2 cocoa-based products containing coffee twice per day
Trial: 18679151
Drug: Micafungin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micafungin (2 mg/kg)
Trial: 18679151
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (3 mg/kg)
Trial: 15583955
Drug: Cerebrolysin 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerebrolysin 50 mL/day for 21 days
Trial: 12853587
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (dalteparin) at a dose of 200 IU per kilogram subcutaneously once daily for five to seven days and a coumarin derivative for six months (target INR 2.5)
Trial: 12853587
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant (coumarin derivative)
Trial: 8967154
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba special extract EGb 761 (3 times 1 film-coated tablet of 40 mg per day)
Trial: 1737539
Drug: Two-dose insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dose insulin regimen (15% regular, 85% NPH) given before breakfast and dinner
Trial: 1737539
Drug: Four-dose insulin
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four-dose insulin regimen (regular insulin before meals and NPH at 2200)
Trial: 6202098
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg propranolol (Inderal)
Trial: 31486833
Drug: EGFR-TKIs plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGFR-TKIs plus metformin (500 mg twice a day)
Trial: 24938504
Drug: Network treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Network treatment (intervention group)
Trial: 22252217
Drug: Tadalafil 20
RxNorm normalized name: tadalafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 20 mg 3 times/week
Trial: 20846257
Drug: Oral 600
RxNorm normalized name: tolmetin
DrugBank: Tolmetin (DB00500)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 600 microg misoprostol
Trial: 20846257
Drug: Sublingual 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual 600 microg misoprostol
Trial: 19092248
Drug: CR oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CR oxycodone plus pregabalin
Trial: 12915604
Drug: High-dose IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IV IL-2 (720,000 U/kg)
Trial: 12915604
Drug: Low-dose IV
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose IV IL-2 (72,000 U/kg)
Trial: 12915604
Drug: Low-dose daily
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose daily subcutaneous IL-2
Trial: 10485635
Drug: Venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine XR (75 or 150 mg/day)
Trial: 10485635
Drug: Buspirone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (30 mg/day in 3 divided doses)
Trial: 8738759
Drug: R-methadone (tablets)
RxNorm normalized name: methadone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-methadone (tablets)
Trial: 8738759
Drug: S-methadone (tablets)
RxNorm normalized name: methadone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-methadone (tablets)
Trial: 2016246
Drug: Exposure therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure therapy for 3 or 6 weeks
Trial: 2016246
Drug: Exposure therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure therapy (6 weeks vs. 3 weeks)
Trial: 2016246
Drug: Exposure therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure therapy homework compliance
Trial: 7127999
Drug: Sustained-release furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release furosemide (FR, 60 mg)
Trial: 7127999
Drug: Conventional furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional furosemide tablet (F, 40 mg)
Trial: 26729582
Drug: CsA monotherapy
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CsA monotherapy (n = 98)
Trial: 18396071
Drug: Fluoropassiv patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoropassiv patch
Trial: 18396071
Drug: Venous patch
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venous patch
Trial: 12873261
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 400 mg
Trial: 10925929
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream (20 g) applied perioperatively and daily for 4 days post-surgery
Trial: 8677990
Drug: Mesalamine suspension
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mesalamine suspension enema (4 g at night)
Trial: 8677990
Drug: Oral sulfasalazine
RxNorm normalized name: Sulfasalazine
DrugBank: Sulfasalazine (DB00795)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sulfasalazine (1 g four times a day)
Trial: 1986150
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy group - three monthly doses of 500 micrograms of TAA emulsified with CFA
Trial: 1986150
Drug: Nonspecific immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonspecific immunotherapy group - three monthly doses of CFA emulsified in saline
Trial: 6653642
Drug: Propranolol (P)
DrugBank: Propranolol (DB00571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propranolol (P) therapy
Trial: 23153388
Drug: Hypnosis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypnosis treatment (5 sessions over 2 months)
Trial: 17163277
Drug: Average dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Average dose of Ziprasidone
Trial: 3541946
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate inhaled as a dry-powder, 400 micrograms twice daily
Trial: 3541946
Drug: Conventional aerosol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional aerosol, 100 micrograms four times daily
Trial: 29683755
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 600 mg orally twice daily from day 0 to 5
Trial: 22748952
Drug: Third-generation thermal
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third-generation thermal uterine balloon therapy (UBT) system with no post-procedure curettage (PPC)
Trial: 22748952
Drug: Third-generation thermal
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third-generation thermal uterine balloon therapy (UBT) system with post-procedure curettage (PPC)
Trial: 8984859
Drug: Bupivacaine 0.0625%
RxNorm normalized name: BUPIVACAINE 0.0625%/NS INJ 250ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.0625% with 2.5 micrograms.ml‐1 fentanyl
Trial: 1754638
Drug: Green light
RxNorm normalized name: light green SF yellowish
DrugBank: Light green SF yellowish (DB11183)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green light treatment (2 hours each morning for 1 week)
Trial: 1754638
Drug: White light
RxNorm normalized name: Light White Mineral Oil
DrugBank: Light mineral oil (DB11579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White light treatment (2 hours each morning for 1 week)
Trial: 1754638
Drug: Sequence of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequence of treatment conditions
Trial: 7428802
Drug: Fluoride 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride 3.0 mg as sodium fluoride tablets during acid urine production (induced by NH4Cl)
Trial: 7428802
Drug: Fluoride 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride 3.0 mg as sodium fluoride tablets during alkaline urine production (obtained by NaHCO3)
Trial: 28586162
Drug: DP10-60 ITF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DP10-60 ITF (8 g/day)
Trial: 28586162
Drug: DP2-25 ITF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DP2-25 ITF (8 g/day)
Trial: 28586162
Drug: Fructose placebo
RxNorm normalized name: Fructose
DrugBank: Fructose (DB04173)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fructose placebo (8 g/day)
Trial: 15036742
Drug: Normothermic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normothermic therapy
Trial: 10660238
Drug: PCEA solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCEA solution of 0.0625% bupivacaine and fentanyl 2 microg/mL (4 mL demand bolus, 15 min lockout) with clonidine 4.5 microg/mL (group BFC)